Tiger Global-backed Bright Health aims for over $14 billion valuation in U.S. IPO

(Reuters) - Bright Health Group, a health insurtech firm backed by Tiger Global and Blackstone, is aiming for a valuation of more than $14 billion in its U.S. initial public offering, according to a regulatory filing on Tuesday.

Bright Health runs two businesses, NeueHealth and Bright HealthCare, through which it offers virtual and in-person clinical care to patients through affiliated primary care clinics and also sells Medicare and commercial health insurance to about 623,000 consumers in the United States.

The company raised $500 million in a late-stage funding round in September last year from investors such as Tiger Global Management, T. Rowe Price Associates and Blackstone Group Inc, bringing total equity raised to over $1.5 billion.

Bright Health, co-founded in 2015 by UnitedHealth Group Inc's former chief executive officer Bob Sheehy, said it would sell 60 million shares priced at between $20.00 and $23.00 per share on the New York Stock Exchange, raising about $1.38 billion.

The potential listing comes as more people sought remote healthcare during the COVID-19 pandemic, supercharging the telemedicine market and prompting companies to expand their scale.

Health insurance startup Oscar Health, backed by Google parent Alphabet Inc, was valued at over $7 billion in its market debut in March, while Clover Health last year agreed to go public through a merger with a blank-check firm backed by venture capitalist Chamath Palihapitiya.

Bright Health generated over $1.2 billion in revenue in 2020, underscoring a boom in the healthcare technology sector.

J.P. Morgan, Goldman Sachs, Morgan Stanley and Barclays are the lead underwriters for the offering.

(Reporting by Noor Zainab Hussain and Sohini Podder in Bengaluru; Editing by Maju Samuel)